Company Analysis

Pulse Biosciences, Inc (PLSE)

Nasdaq: PLSE · Surgical & Medical Instruments & Apparatus · Hayward, CA · filing with the SEC since 2014
Grade3.3
◀ Past 2.4● Present 2.8▶ Future 4.7
2 est.

Filings

377 filings since 2017 beside 227 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 36 days after the quarter ended. The proxy statement was last filed May 11, 2026.

Filings a yearinsider forms included
3956534876804967
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 12 times in the last 36 months, the newest Apr 9, 2026.SEC letters: 12 in the last 36 months, the newest Feb 25, 2026.A late-filing notice, Form NT 10-Q, filed Aug 15, 2024.
Insider forms 227

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 6, 2026 8-K items 8.01, 9.01 Other event · Current report
Nov 5, 2026 10-Q Quarterly report Sep 30, 2026
Nov 5, 2026 8-K items 2.02, 9.01 Results released · Current report
Oct 14, 2026 8-K items 8.01, 9.01 Other event · Current report
Oct 7, 2026 8-K items 8.01, 9.01 Other event · Current report
Sep 15, 2026 8-K items 1.01, 1.02, 9.01 Major agreement signed; Major agreement ended · Current report Sep 14, 2026
Sep 15, 2026 424B5 Shelf offering
Sep 15, 2026 8-K items 8.01, 9.01 Other event · Current report
Aug 6, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report
Aug 6, 2026 424B5 Shelf offering
Aug 6, 2026 10-Q Quarterly report Jun 30, 2026
Aug 6, 2026 8-K items 2.02, 9.01 Results released · Current report
Jul 29, 2026 8-K items 8.01, 9.01 Other event · Current report
Jun 12, 2026 8-K item 5.07 Shareholder vote · Current report Jun 11, 2026
Jun 10, 2026 8-K items 8.01, 9.01 Other event · Current report
May 14, 2026 10-Q Quarterly report Mar 31, 2026
May 13, 2026 SCHEDULE 13D/A Activist holder update, amended
May 11, 2026 DEF 14A Proxy statement Jun 11, 2026
May 6, 2026 8-K item 8.01 Other event · Current report May 5, 2026
May 4, 2026 8-K items 2.02, 8.01, 9.01 Results released; Other event · Current report
Apr 30, 2026 10-K/A Annual report, amended Dec 31, 2025
Apr 27, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report Apr 25, 2026
Apr 16, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Apr 9, 2026 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report Apr 8, 2026
Apr 7, 2026 8-K items 8.01, 9.01 Other event · Current report
Mar 27, 2026 8-K item 5.02 Officer or director change · Current report Mar 23, 2026
Mar 17, 2026 8-K items 8.01, 9.01 Other event · Current report
Mar 12, 2026 8-K items 8.01, 9.01 Other event · Current report
Mar 9, 2026 8-K items 8.01, 9.01 Other event · Current report Mar 6, 2026
Mar 3, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Mar 2, 2026 8-K/A items 5.02, 9.01 Officer or director change · Current report, amended Feb 27, 2026
Feb 27, 2026 EFFECT Registration effective
Feb 27, 2026 8-K items 5.02, 9.01 Officer or director change · Current report
Feb 25, 2026 CORRESP Reply to the SEC
Feb 25, 2026 UPLOAD SEC comment letter
Feb 19, 2026 8-K items 2.02, 9.01 Results released · Current report
Feb 19, 2026 S-3 Shelf registration
Feb 19, 2026 S-8 Employee stock plan registration
Feb 19, 2026 424B5 Shelf offering
Feb 19, 2026 8-K items 1.01, 1.02, 9.01 Major agreement signed; Major agreement ended · Current report Feb 18, 2026
40 of 377 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton PLSE · research, not advice